Table 2 Literature review
Year | Authors | Procedure | Scheduled or Urgent | Comorbidity | Pre-operative testing | Temp | Cardioplegia | Normothermia | Other treatment | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|
2001 | Takeishi et al | Atrial myxoma | --- | Proteinuria, Raynaud phenomenon Purpura | None | Hypothermic | Cold | No | None | Positive |
2006 | Fontana et al | Tirone David | Scheduled | HIV/HCV | None | 22–24 °C | Cold | No | None | Positive |
2017 | Fakih et al | Coronary artery bypass graft | Scheduled | Idiopathic cryoglobulinemia chronic kidney disease, hypertension, coronary artery disease | Cryo + | 32.4 °C | Warm | Yes | Plasmapheresis pre-op, Steroids pre-op, Immunosuppressive therapy pre-op | Positive |
2017 | Satomi et al | Aortic valve replacement | Scheduled | Hypertension, Waldestrom’s Macroglobulinemia | Cryo + | 37 °C | Warm | Yes | None | Positive |
2019 | Vela et al | Mitral + aortic valve replacement | Urgent | HCV, endocarditis | Cryo + | 37 °C | Warm | Yes | Plasma Exchange/Plasmapheresis pre-op, Steroids post-op | Negative |
2020 | Yamazaki et al | Ascending aorta replacement | Urgent | Idiopathic cryoglobulinemia | None | 17 °C | Cold | No | Plasma Exchange/Plasmapheresis pre-op, Steroids pre-op, Immunosuppressive therapy pre-op | Positive |
2020 | Saifullah et al | Mitral valve repair + coronary artery bypass graft | Scheduled | Idiopathic cryoglobulinemia, diabetes, hypertension, hypercholesterolemia | Cryo + | 34 °C | Warm | Yes | Plasmapheresis pre and post-op, Steroids pre-op | Positive |
2022 | Panagiotopoulos et al | Coronary artery bypass graft | Scheduled | Diabetes, hypercholesterolemia | None | Hypothermic | From Cold to Warm | No | None | Positive |
2023 | Edmiston et al | Mitral valve Substitution | Scheduled | Type II cryoglobulinemia, cryoglobulinemic glomerulonephritis (renal failure stage III) | Cryo + | Normothermic | Cold | Yes | Plasma exchange pre-op, Chronic Steroids pre-op, Immunosuppressive therapy pre-op | Positive |